SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00079



SampleIDNumReplicatesOrganismTissueTypeCellTypeMHCAllele
SampleID
NumReplicates
Organism
TissueType
CellType
MHCAllele
SYSMHC00079_DPrep1 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep2 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep3 4 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep4 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DPrep5 16 Human HLA-DPA10201-DPB10401,HLA-DPA10202-DPB10401
SYSMHC00079_DQrep1 19 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep2 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep3 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep4 4 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep5 6 Human HLA-DQA10505-DQB10301
SYSMHC00079_DQrep6 16 Human HLA-DQA10505-DQB10301
SYSMHC00079_DRrep1 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep2 8 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep3 4 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep4 16 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep5 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep6 15 Human DRB1_1201,DRB3_0202
SYSMHC00079_DRrep7 31 Human DRB1_1201,DRB3_0202
Showing 1 to 11 of 18 entries



Detailed view of sample SYSMHC00079_DRrep7



IDSampleIDRawFileNameProcessCulture ConditionsDisease StateCommentsMHCClassPubMed IDPeptideIsolation MethodAntibodyMass SpectrometerLC SystemiRT PeptidesAcquisition ModeFragmentation MethodGradientGradient LengthFlow RateReplicate Number
ID
SampleID
RawFileName
Organism
Process
Tissue Type
Cell Type
Culture Conditions
Disease State
Comments
MHCClass
MHCAllele
PubMed ID
Peptide
Isolation Method
Antibody
Mass Spectrometer
LC System
iRT Peptides
Acquisition Mode
Fragmentation Method
Gradient
Gradient Length
Flow Rate
Replicate Number
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A10.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 1
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A11.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 2
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A12.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 3
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A13.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 4
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A14.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 5
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A15.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 6
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A3.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 7
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A4.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 8
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A5.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 9
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A6.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 10
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A7.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 11
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A8.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 12
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_A9.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 13
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B10.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 14
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B11.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 15
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B12.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 16
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B13.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 17
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B14.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 18
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B15.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 19
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B1.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 20
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B2.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 21
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B3.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 22
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B4.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 23
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B5.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 24
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B6.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 25
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B8.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 26
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_B9.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 27
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C1.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 28
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C2.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 29
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C3.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 30
SYSMHC00079 SYSMHC00079_DRrep7 DRrep7_C4.wiff In vitro suspension EBV transformed class II PXD025877 native Immunoaffinity LB3.1 Triple-TOF 5600 no DDA CID-QTOF 90 300 nL/min 31
Showing 1 to 4 of 31 entries